Background The project to build a “Medication Workshop” kit has been designed by AFLAR (French Association Against Rheumatic diseases, recognized of public utility) in order to provide health professionals and patient associations a set of tools to deliver educational workshops to good use (in terms of optimal efficiency, safety and autonomy) of medications – prescribed or not – and frequently used in rheumatic diseases. A multidisciplinary board was created to identify key messages to be conveyed to patients for each therapeutic class, and learning tools ready to be used by animators.
A group of expert patients, mostly long-time volunteers of the association at the patients'help line and hospital patient meetings, was formed and consulted on priority messages and teaching methods, as always done by AFLAR for such projects.
Objectives The workshops were designed to last 1.30-2 hours. They are intended for all patients likely to use analgesics, nonsteroidal anti-inflammatory drugs or oral corticosteroids, whether newly or previously diagnosed.
These group sessions can either be used in general health education, or as part of standardized patient education programs that meets the 2007 Recommendations the High Authority of Health in France and Law “No. 2009-879 of 21 July 2009” and its implementing decrees about patient education.
Methods The animation methods used were: definition building by the group, group discussion, activity of recognition and sorting of drug boxes, Barrow cards, group summary and answers/individual additions, raised questions related participants about and response by the co-animating expert caregiver.
The workshops have been tested with groups of patients in a U hospital rheumatology department and in a “patients association house” of a second hospital, and during 1st National Meeting for patients about Rheumatism, multi- associative Congress initiated by AFLAR, ANDAR and AFS patient associations. An evaluation questionnaire had been designed and used during these test sessions.
Results The feedback from patients shows great satisfaction of audience, with a score of response to the expectations of 9/10; 18 of 19 patients felt that the proposed activities were useful, and 17 of 19 patients were ready to come back for another workshop.
The “supply of knowledge” domain received the lowest score, 8.4 out of 10, additional questions have arisen in each test, asking to enrich content with physiological patterns, and general answers on about the diseases, medications, or diets. Workshops' test sessions were also filmed to produce video demonstration to medical teams or associations wishing to use the whole tool kit, which will be available free of charge on www.aflar.org. After each use of the kit, the organizers will be asked the to enrich the workshop with their own feedback.
Conclusions The AFLAR Medication Workshops constitute an original initiative in terms of education for patient safety, still underdeveloped in France. They can be used by healthcare facilities as part of education for patient safety, by patient groups or associations, in usual practice or for example on the occasion of the yearly European Week for patient safety.
Acknowledgements The project was funded by ANSM, French agency for drug safety.
Disclosure of Interest None declared